癌症中调节失调的线粒体动力学:释放打击耐药性的新策略
Teresa Rossi1, Roberta Torcasio2, Ludovica Ganino2
1Laboratory of Translational Research, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Biochimica et biophysica acta. Reviews on cancer
|December 8, 2025
概括
细胞功能至关重要的线粒体动力学在癌症中被破坏,促进瘤生长和耐药性. 准DRP1等关键蛋白质为晚期癌症提供了新的治疗途径.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体动力学,融合和裂变之间的平衡,对于代谢和亡等细胞过程至关重要.
- 异常的线粒体动力学与侵袭性癌症有关,并有助于治疗耐药性.
研究的目的:
- 审查线粒体动态的调节机制.
- 探索遗传和表观遗传因素在调节关键线粒体动力学蛋白质 (DRP1,MFN1/2,OPA1) 中的作用.
- 讨论如何改变线粒体动力学有助于癌症药物耐药性.
主要方法:
- 文献综述侧重于线粒体动态的遗传和表观遗传调节.
- 分析线粒体动态与癌症进展之间的联系.
- 检查与线粒体动态相关的药物耐药性背后的机制.
主要成果:
- 线粒体动力学受到影响DRP1,MFN1/2和OPA1.2等蛋白质的遗传和表观遗传机制的调节.
- 不调节的线粒体动力学促进癌症恶性转变和瘤进展.
- 改变的线粒体动力学与抗常规和向抗癌疗法的耐药性有关.
结论:
- 异常的线粒体动力学作为癌症治疗耐药性的潜在生物标志物.
- 与线粒体动力学相关的GTPase,特别是DRP1和Mitofusins,代表了先进的固体和血液恶性瘤的有前途的治疗标.
更多相关视频
07:58An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
7.4K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.1K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Mitochondrial Membranes
16.5K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.5K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
